Design, synthesis and pharmacological characterization of the first photoswitchable small-molecule agonist for the Atypical Chemokine Receptor 3

Abstract

1.AbstractPhotopharmacology offers the promise of optical modulation of cellular signaling in a spatially and temporally controlled fashion with light-sensitive molecules. This study presents the first small-molecule photoswitchable agonist for an atypical G protein-coupled receptor (GPCR), the atypical chemokine receptor 3 (ACKR3). Inspired by a known benzylpiperidine-based ACKR3 agonist scaffold, 12 photoswitchable azobenzene-containing analogs were synthesized and characterized for their interaction with ACKR3. After analysis of Structure-Photochemistry and Structure-Affinity Relationships (SAR), compound3ewas selected as the best photoswitchable ACKR3 agonist in the series. Compound3ecan be effectively switched from its thermodynamically stabletransstate to the less activecis-isomer with a PhotoStationary State of 96 %. The thermodynamically less stablecis-3eonly slowly switches back to thetransstate (t1/2,37 °C= 15 days), andtrans-3ebinds and activates ACKR3 at 10-fold lower concentrations compared to itscis-isomer. Compound3edemonstrates selectivity for ACKR3 within in a panel of chemokine receptors. Using the recently published ACKR3 cryo-EM structures in computational studies, a binding mode fortrans-3eis proposed and is perfectly in line with the observed SAR and the loss of interaction with ACKR3 upon photoswitching. ACKR3 agonist3e(VUF25471) is the first photoswitchable ligand for an atypical GPCR and will be a useful tool to investigate the role of ACKR3 in biological settings.